Pharmacosurveillance - Pharmacovigilance

mardi 14 juin 2022
Sessions parallèles
Sessions parallèles S11 13h30 > 15h00 Pharmacosurveillance - Pharmacovigilance Amphi Congrès Sessions parallèles

Modérateurs : Marion LEPELLEY (Grenoble), Annie-Pierre JONVILLE-BERA (Tours)

Conférence invitée
13h30 Quel impact de la crise sanitaire sur la détection et l'analyse du signal en Pharmacovigilance ? - Annie-Pierre JONVILLE-BERA (Tours) et Céline MOUNIER, ANSM (Paris)

Communications libres

CO-007 CO-007 - Nonsteroidal anti-inflammatory drugs exposure in complicated acute community-acquired bacterial infections, a French multicentre case-control study (ANAIG) > G. Gwenaëlle VEYRAC CO-008 CO-008 - Iatrogenic consequences of drug shortage: the CIRUPT Study from the French Network of Regional Pharmacovigilance Centers > D. Delphine BOURNEAU-MARTIN CO-009 CO-009 - Lack of therapeutic efficacy: a picture of notified cases to the French PV network > M-B. Marie-Blanche VALNET RABIER CO-010 CO-010 - 3 M syndrom (Myasthenia myositis myocarditis) related to nivolumab treatment > F. Frank ROUBY CO-011 CO-011 - Lamotrigine associated serotonin syndrome: analysis of the reports in VigiBase® > B. Basile CHRÉTIEN CO-012 CO-012 - Associations between Th1-mediated diseases and omalizumab: a post-marketing study of the World Health Organization pharmacovigilance database (VigiBase®) > B. Benjamin BATTEUX

Copyright © key4events - All rights reserved